Read the First Edition of The Lens, a new magazine by LSI
Learn More About BioAssets Development Corporation (aka BDC) (Acquired)
BioAssets Development Corporation (aka BDC) (Acquired)
image
Tumor necrosis factor alpha (TNF-a) inhibitor therapy for treatment of chronic persistent radiculopathy (including sciatica) related to disc herniation.
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
CEO presentation
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next